The Clinical Research Site began operations in September 2011 for the purpose of conducting clinical trials sponsored by the pharmaceutical industry to help new drugs reach patients.
In the first 5 years, 44 Phase 2 and 3 clinical trials have been successfully completed, in several of which Clinstile was a high recruiter at national and global levels. Due to its high performance, Clinstile has successfully passed audits from CRO, sponsor and MoH.
Clinstile has positioned itself as a quality clinical research site, seeking to meet and exceed the recruitment projections with proactive strategies, keeping up-to-date SOPs for all the procedures that are carried out, ensuring fast and flexible processes for the implementation of clinical trials.
To carry out Phase 2, 3 and 4 clinical trials of the therapeutic areas urology, rheumatology, endocrinology, cardiology, pulmonology, neurology under strict quality and ethical standards, always seeking the welfare of our patients and the satisfaction of our clients.
Become a leading research site in the therapeutic areas in which we perform.
- Quality of our services
- Professional ethics
- Community welfare